Faculty, Staff and Student Publications

Language

English

Publication Date

2-1-2025

Journal

NeoReviews

DOI

10.1542/neo.26-2-011

PMID

39889768

PMCID

PMC12079657

PubMedCentral® Posted Date

5-15-2025

PubMedCentral® Full Text Version

Author MSS

Abstract

The metabolome and lipidome comprise the thousands of molecular compounds in an organism. Molecular compounds consist of the upstream metabolic components of intracellular reactions or the byproducts of cellular pathways. Molecular and biochemical perturbations are associated with disorders in newborns and infants. The diagnosis of inborn errors of metabolism has relied on targeted metabolomics for several decades. Newer approaches offer the potential to identify novel biomarkers for common diseases of the newborn and infant. They may also elucidate novel predictive or diagnostic measures for a variety of health trajectories. Here, we review the relevance of the metabolome and lipidome for common disorders and highlight challenges and opportunities for future investigations.

Keywords

Humans, Metabolomics, Infant, Newborn, Lipidomics, Intensive Care Units, Neonatal, Biomarkers, Metabolism, Inborn Errors

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.